X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
female (19) 19
index medicus (19) 19
aged (18) 18
male (18) 18
stroke (17) 17
clinical neurology (15) 15
middle aged (13) 13
stroke - drug therapy (12) 12
treatment outcome (12) 12
medicine, general & internal (10) 10
clinical trials (9) 9
mortality (9) 9
abridged index medicus (8) 8
peripheral vascular disease (8) 8
stroke - mortality (8) 8
time factors (8) 8
aged, 80 and over (7) 7
care and treatment (7) 7
internal medicine (7) 7
patient outcomes (7) 7
therapy (7) 7
tissue plasminogen activator (7) 7
analysis (6) 6
acute disease (5) 5
acute ischemic-stroke (5) 5
adult (5) 5
double-blind method (5) 5
drug therapy (5) 5
health aspects (5) 5
ischemia (5) 5
neurology (5) 5
neuroprotection (5) 5
neurosciences (5) 5
randomized controlled trials as topic (5) 5
research (5) 5
risk factors (5) 5
thrombolysis (5) 5
atlantis (4) 4
biography (4) 4
double-blind (4) 4
fibrinolytic agents - administration & dosage (4) 4
fibrinolytic agents - adverse effects (4) 4
infusions, intravenous (4) 4
metaanalysis (4) 4
odds ratio (4) 4
proportional hazards models (4) 4
severity of illness index (4) 4
stroke - etiology (4) 4
tissue plasminogen activator - administration & dosage (4) 4
tissue plasminogen activator - adverse effects (4) 4
tissue-plasminogen activator (4) 4
architectural historians (3) 3
brain (3) 3
complications and side effects (3) 3
ecass (3) 3
fibrinolytic agents - therapeutic use (3) 3
follow-up studies (3) 3
further section (3) 3
great britain (3) 3
hemorrhage (3) 3
history (3) 3
injections, intravenous (3) 3
lees-milne, james (3) 3
logistic models (3) 3
medical treatment (3) 3
medicine (3) 3
national trust (3) 3
original paper (3) 3
patients (3) 3
predictive value of tests (3) 3
prognosis (3) 3
recovery of function (3) 3
retrospective studies (3) 3
risk assessment (3) 3
safety (3) 3
stroke - blood (3) 3
stroke - physiopathology (3) 3
studies (3) 3
surgery (3) 3
tissue plasminogen activator - therapeutic use (3) 3
tomography, x-ray computed (3) 3
united kingdom (3) 3
united states (3) 3
acute ischemic stroke (2) 2
age (2) 2
age factors (2) 2
animals (2) 2
article (2) 2
articles (2) 2
auslandsinvestition (2) 2
autobiographies (2) 2
biomarkers - blood (2) 2
blood (2) 2
blood clot (2) 2
blood glucose - metabolism (2) 2
blood pressure (2) 2
brain ischemia - complications (2) 2
cerebral hemorrhage - chemically induced (2) 2
cerebral infarction (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (8) 8
UTL at Downsview - May be requested (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Gerstein Science - Stacks (2) 2
Music - Stacks (2) 2
OISE - Stacks (2) 2
Earth Sciences (Noranda) - Circulation Desk (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Online Resources - Online (1) 1
Physics - Circulation Desk (1) 1
Physics - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9958, pp. 1929 - 1935
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9727, pp. 1695 - 1703
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10069, pp. 603 - 611
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2016, Volume 15, Issue 9, pp. 925 - 933
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9646, pp. 1303 - 1309
Summary Background Intravenous alteplase is approved for use within 3 h of ischaemic stroke onset, although a meta-analysis of randomised controlled trials... 
Internal Medicine | Stroke (Disease) | Complications and side effects | Care and treatment | Tissue plasminogen activator | Patient outcomes | Diagnosis | Thrombosis | Health aspects | Blood clot | Risk factors
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2010, Volume 9, Issue 9, pp. 866 - 874
Summary Background In September, 2008, the European Acute Stroke Study III (ECASS III) randomised trial and the Safe Implementation of Treatment in... 
Neurology | Stroke (Disease) | Clinical trials | Neurosciences | Universities and colleges | Tissue plasminogen activator
Journal Article